Understanding and Kinetic Modeling of Complex Degradation Pathways in the Solid Dosage Form: The Case of Saxagliptin
Drug substance degradation kinetics in solid dosage forms is rarely mechanistically modeled due to several potential micro-environmental and manufacturing related effects that need to be integrated into rate laws. The aim of our work was to construct a model capable of predicting individual degradat...
Saved in:
Main Authors: | Blaž Robnik (Author), Blaž Likozar (Author), Baifan Wang (Author), Tijana Stanić Ljubin (Author), Zdenko Časar (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Novel Testing Approach for Oxidative Degradation Dependent Incompatibility of Amine Moiety Containing Drugs with PEGs in Solid-State
by: Blaž Robnik, et al.
Published: (2020) -
Stability indicating RP-LC-PDA method for the quantitative analysis of saxagliptin in pharmaceutical dosage form
by: Laís Engroff Scheeren, et al.
Published: (2015) -
Application of quality by design approach in RP-HPLC method development for simultaneous estimation of saxagliptin and dapagliflozin in tablet dosage form
by: Aruna Gundala, et al.
Published: (2019) -
Study of the dissolution kinetics of drugs in solid dosage form with lisinopril and atorvastatin and intestinal permeability to assess their equivalence in vitro
by: Nataliia Shulyak, et al.
Published: (2022) -
On the Stability and Degradation Pathways of Venetoclax under Stress Conditions
by: Nina Žigart, et al.
Published: (2020)